Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
Dobkin
Bruce H
BH
Landau
William M
WM
Sahrmann
Shirley
S
Thomas Thach
W
W
Simpson
D M
DM
Gracies
J-M
JM
Graham
K
K
Hallett
M
M
Miyasaki
J
J
Naumann
M
M
Russman
B
B
Simpson
L
L
So
Y
Y
D001905:Botulinum Toxins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D020127:Recovery of Function / Q000187:drug effects / Q000502:physiology; D020521:Stroke / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D001905:Botulinum Toxins